TRAW
Traws Pharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.24M
P/E Ratio
—
EPS
$-1.87
Beta
1.45
52W High
$3.27
52W Low
$0.99
50-Day MA
$1.50
200-Day MA
$1.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Traws Pharma Inc
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania.
Fundamentals
| Revenue (TTM) | $2.73M |
| Gross Profit (TTM) | $2.73M |
| EBITDA | $-19.51M |
| Operating Margin | -718.00% |
| Return on Equity | -5639.00% |
| Return on Assets | -90.10% |
| Revenue/Share (TTM) | $0.30 |
| Book Value | $-0.07 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 7.04 |
| EV/Revenue | 5.87 |
| EV/EBITDA | 0.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $15.15M |
| Float | $11.73M |
| % Insiders | 9.44% |
| % Institutions | 44.15% |
Historical Volatility
HV 10-Day
55.12%
HV 20-Day
87.84%
HV 30-Day
123.33%
HV 60-Day
119.33%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($5.50 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026